In the selected key specific DEGs for LumB-subtype breast cancer, the expression of CNTD2, NEURL, STAC2, AKR1C2, IL6, FREM1, and HOXA4 were significantly correlated with the prognostic survival of the patients. Here, FREM1 is linked to breast carcinoma.